Abbo LM - Search Results

1

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.

Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Oñate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltrán SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordoñez K, Wang M, Stryjewski ME, Munita JM, Paterson DL, Evans S, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG Jr, Doi Y, van Duin D, Satlin MJ; Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators. Reyes J, et al. Among authors: abbo lm. Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9. Lancet Microbe. 2023. PMID: 36774938 Free PMC article.

2

Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.

Abbo L, Vincek V, Dickinson G, Shrestha N, Doblecki S, Haslett PA. Abbo L, et al. Clin Infect Dis. 2007 Feb 1;44(3):e25-7. doi: 10.1086/510426. Epub 2006 Dec 29. Clin Infect Dis. 2007. PMID: 17205432

3

Polymyxin B-induced skin hyperpigmentation.

Li YM, Milikowski C, Selvaggi G, Abbo LM, Skiada D, Galimberti F. Li YM, et al. Among authors: abbo lm. Transpl Infect Dis. 2020 Oct;22(5):e13312. doi: 10.1111/tid.13312. Epub 2020 May 27. Transpl Infect Dis. 2020. PMID: 32386075

4

Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase (bla_VIM): infection management and molecular analysis.

Vega AD, DeRonde K, Jimenez A, Piazza M, Vu C, Martinez O, Rojas LJ, Marshall S, Yasmin M, Bonomo RA, Abbo LM. Vega AD, et al. Among authors: abbo lm. Antimicrob Agents Chemother. 2024 May 2;68(5):e0147423. doi: 10.1128/aac.01474-23. Epub 2024 Apr 11. Antimicrob Agents Chemother. 2024. PMID: 38602418

5

Navigating the Challenges of Candida auris Colonization in Rehabilitation Settings.

Shapiro LT, Valecillos AV, McDade R, Rosa RM, Abbo LM. Shapiro LT, et al. Among authors: abbo lm. Rehabil Nurs. 2024 May-Jun 01;49(3):80-85. doi: 10.1097/RNJ.0000000000000455. Epub 2024 Feb 16. Rehabil Nurs. 2024. PMID: 38386804 Review.

6

Impact of In-house Candida auris Polymerase Chain Reaction Screening on Admission on the Incidence Rates of Surveillance and Blood Cultures With C. auris and Associated Cost Savings.

Rosa R, Jimenez A, Andrews D, Dinh H, Parra K, Martinez O, Abbo LM. Rosa R, et al. Among authors: abbo lm. Open Forum Infect Dis. 2023 Nov 10;10(11):ofad567. doi: 10.1093/ofid/ofad567. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023537 Free PMC article.

7

Effectiveness of a sodium hypochlorite isotonic solution in decolonization of patients with Candida auris: Learnings from a county health care system.

Rosa R, Abbo LM, Jimenez A, Carter C, Ruiz M, Gerald W, Jimenez Hamann M. Rosa R, et al. Among authors: abbo lm. Am J Infect Control. 2024 May;52(5):595-598. doi: 10.1016/j.ajic.2023.11.008. Epub 2023 Nov 23. Am J Infect Control. 2024. PMID: 38007101

8

Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action.

Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators. Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators. World J Emerg Surg. 2023 Oct 16;18(1):50. doi: 10.1186/s13017-023-00518-3. World J Emerg Surg. 2023. PMID: 37845673 Free PMC article. Review.

9

Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.

Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, Figueroa J, Herc E, Cordova E, Weston G, Ananth Tambyah P, Garcia-Diaz J, Kaye KS, Dhar S, Munita JM, Salata RA, Vilchez S, Stryjewski ME, Villegas Botero MV, Iovleva A, Evans SR, Baum K, Hill C, Kreiswirth BN, Patel R, Paterson DL, Arias CA, Bonomo RA, Chambers HF, Fowler VG Jr, Satlin MJ, van Duin D, Doi Y; Multi-Drug Resistant Organism Network Investigators. Wang M, et al. Clin Infect Dis. 2024 Feb 17;78(2):248-258. doi: 10.1093/cid/ciad556. Clin Infect Dis. 2024. PMID: 37738153

10

Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies.

Abbo LM, Vasiliu-Feltes I. Abbo LM, et al. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0075123. doi: 10.1128/aac.00751-23. Epub 2023 Sep 19. Antimicrob Agents Chemother. 2023. PMID: 37724872 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page